A.K. PHARMA
Board
1 director, no change since 2025Sole director (not named in the articles)
in office according to the deed of 13-06-2025
term without a fixed end
earlier manager, until 13-06-2025
Mandates through the years
1 name, the dashed line is todaySole director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Sole director (not named in the articles), since before 13-06-2025
- Manager, until 13-06-2025
With Starter you also see 2 former office holders in the mandate history.
See the plans →
Control
Shares transferred to
This company
A.K. PHARMA
Equity €331,908
Profit €72,703 in 2024
Capital
- Capital
- €18,600
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- €3,319 in 2024
- Source
- 2024 annual accounts
Articles of association
deed of 13-06-2025 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 30 June at 20:00
Shareholders
Share transfer
deed of 30-10-2015 ↗
- to 50 shares
At incorporation
deed of 18-08-2014 ↗
- 50 shares (50%)
- 50 shares (50%)